Donald Trump Stocks – The Pharmaceutical Play You Need To Make Right Now

Being that Donald Trump has tapped Tom Price as his secretary of Health and Human Services and SeemaVerma to head up the Centers for Medicare and Medicaid Services, it’s safe to say the healthcare system is poised to undergo some serious changes in the very near future.

This is because Donald Trump and his administration are fixated on the idea of lowering the cost of healthcare in the United States. And from the looks of it, they are willing to do almost anything to make sure this happen.

Right now Trump is proposing the red tape at the FDA be cut so that Abbreviated New Drug Applications (ANDAs) for generic drugs can be reviewed and approved at a much quicker rate.

Right now, due to the unbelievable number of generic drug submissions received by the FDA on a regular basis, there is a backlog of about 3,000 Abbreviated New Drug Applications (ANDAs) that are waiting to be reviewed.

If Trump has his way and the red tape is cut, you can expect a sharp increase in the number of generic drugs that make their way onto the market. To benefit from this sharp increase it would be a smart move to buy stock in Teva Pharmaceutical Industries Ltd, one of the largest generic drug companies in the world.

In mid 2016 Teva Pharmaceutical Industries Ltd acquired the generic drug unit of Allergan for billions of dollars. This one move put them in the position to shape how generic drugs will be priced for the foreseeable future.

Currently Teva Pharmaceutical Industries Ltd has about 300 Abbreviated New Drug Applications (ANDAs) on file with the FDA. That means if certain healthcare reforms should take place, they would be one of the biggest potential beneficiaries of those reforms.

But here is what will make investing in Teva right now not only a smart move, but a very profitable one as well. Of the 300 or so Abbreviated New Drug Applications (ANDAs) they currently have on file with the FDA, one third of them are first generic drugs.

First generic drugs are the first generic versions of some of the most popular branded drugs currently on the market. First generic drugs, being that they are the first of their kind, tend to have a period of exclusivity when they first hit the market. During that short window you can make a ton of money if you are invested in the company.

What If You Knew Which Way The Stock Market Was About To Move Before It Happened – CLICK HERE!

Related Articles:

Published at: Economic News Articles

Post Footer automatically generated by Add Post Footer Plugin for wordpress.

Article Source

DISCLAIMER: All information, content, and data in this article are sole opinions and/or findings of the individual user or organization that registered and submitted this article at Economic News Articles without any fee. The article is strictly for educational or entertainment purposes only and should not be used in any way, implemented or applied without consultation from a professional. We at Economic News Articles do not, in anyway, contribute or include our own findings, facts and opinions in any articles presented in this site. Publishing this article does not constitute Economic News Articles's support or sponsorship for this article. Economic News Articles is an article publishing service. Please read our Terms of Service for more information.

Comments are closed

Disclosure: You should assume that the owner of this website is an affiliate for providers of goods and services mentioned on this website. The owner may be compensated when you purchase after clicking on a link. The owner may also have received the product for free. Perform due diligence before purchasing from this or any other website. Testimonials may or may not be accurate, and anything that looks like an endoresement should be regarded as nothing more than an advertisement.
%d bloggers like this: